GLOBUS MEDICAL INCGMED财报
NYSE · health technology
Globus Medical, Inc. is a publicly traded orthopedic medical device company headquartered in Audubon, Pennsylvania, United States. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders.
主要股东
| 股东 | 持股比例 | 股数 | 变动 | 截至 |
|---|---|---|---|---|
| of Above Person | 15.76% | 21.3M | — | 2024-02-14 |
| The Vanguard Group | 9.54% | 11.3M | ▼ -4.92pp | 2024-02-13 |
| BlackRock, Inc. | 9.40% | 10.8M | ▼ -2.70pp | 2024-01-24 |
| S.S. OR | 5.20% | 7.0M | ▼ -0.50pp | 2024-11-14 |
| S OR | 0.00% | 379.6M | — | 2024-02-13 |
内部人交易
Net 90d: −$2.77M · buys $0 / sells $2.77M时间范围:
类型:
身份:
| 内部人 | 身份 | 类型 | ||||
|---|---|---|---|---|---|---|
| 2026-02-25 | Kelly Huller | EVP, GC, Corporate Secretary | Option exercise | 20.0K | $43.58 | $871.6K |
| 2026-02-25 | Kelly Huller | EVP, GC, Corporate Secretary | Sell (open market) | 20.0K | $94.50 | $1.89M |
| 2026-02-12 | Kelly Huller | EVP, GC, Corporate Secretary | Option exercise | 10.0K | $45.64 | $456.4K |
| 2026-02-12 | Kelly Huller | EVP, GC, Corporate Secretary | Sell (open market) | 10.0K | $87.67 | $876.7K |
1–4 of 4